{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:11:59Z","timestamp":1787026319967,"version":"build-2736575974"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>\n                    Hypertension is one of the main adverse effects of antiangiogenic tumor drugs and thus limits their application. The mechanism of hypertension caused by tyrosine kinase inhibitors (TKIs) targeting vascular endothelial growth factors is mainly related to inhibition of the nitric oxide (NO) pathway and activation of the endothelin pathway, as well as vascular rarefaction and increased salt sensitivity; consequently, prevention and treatment differ for this type of hypertension compared with primary hypertension. Apatinib is a highly selective TKI approved in China for the treatment of advanced or metastatic gastric cancer. The RhoA\/ROCK pathway is involved in the pathogenesis of hypertension and mediates smooth muscle contraction, eNOS inhibition, endothelial dysfunction and vascular remodeling. In this study,\n                    <jats:italic>in vivo<\/jats:italic>\n                    experiments were performed to explore whether the RhoA\/ROCK signaling pathway is part of a possible mechanism of apatinib in the treatment of gastric cancer-induced hypertension and the impairment of vascular remodeling and left ventricular function. Y27632, a selective small inhibitor of both ROCK1 and ROCK2, was combined with apatinib, and its efficacy was evaluated, wherein it can reduce hypertension induced by apatinib treatment in gastric cancer mice and weaken the activation of the RhoA\/ROCK pathway by apatinib and a high-salt diet (HSD). Furthermore, Y-27632 improved aortic remodeling, fibrosis, endothelial dysfunction, superior mesenteric artery endothelial injury, left ventricular dysfunction and cardiac fibrosis in mice by weakening the activation of the RhoA\/ROCK pathway. The expression of RhoA\/ROCK pathway-related proteins and relative mRNA levels in mice after apatinib intervention were analyzed by various methods, and blood pressure and cardiac function indexes were compared. Endothelial and cardiac function and collagen levels in the aorta were also measured to assess vascular and cardiac fibrosis and to provide a basis for the prevention and treatment of this type of hypertension.\n                  <\/jats:p>","DOI":"10.3389\/fcvm.2022.873829","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T01:06:51Z","timestamp":1655946411000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Research on the Mechanism and Prevention of Hypertension Caused by Apatinib Through the RhoA\/ROCK Signaling Pathway in a Mouse Model of Gastric Cancer"],"prefix":"10.3389","volume":"9","author":[{"given":"Wenjuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runmin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/circulationaha.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer.","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation."},{"key":"B2","doi-asserted-by":"publisher","first-page":"894","DOI":"10.21037\/atm-21-2133","article-title":"A narrative review on the interaction between genes and the treatment of hypertension and breast cancer.","volume":"9","author":"Wang","year":"2021","journal-title":"Ann Transl Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/hjh.0000000000003060","article-title":"Rho kinase inhibition ameliorates vascular remodeling and blood pressure elevations in a rat model of apatinib-induced hypertension.","volume":"40","author":"Li","year":"2022","journal-title":"J Hypertens."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1200\/jco.2015.63.5995","article-title":"Randomized, double-blind, placebo-controlled phase iii trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction.","volume":"34","author":"Li","year":"2016","journal-title":"J Clin Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e3015","DOI":"10.1038\/cddis.2017.422","article-title":"Apatinib promotes autophagy and apoptosis through Vegfr2\/Stat3\/Bcl-2 signaling in osteosarcoma.","volume":"8","author":"Liu","year":"2017","journal-title":"Cell Death Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.canlet.2016.01.015","article-title":"Intracellular autocrine VEGF signaling promotes EBDC cell proliferation, which can be inhibited by apatinib.","volume":"373","author":"Peng","year":"2016","journal-title":"Cancer Lett."},{"key":"B7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12876-018-0870-3","article-title":"Apatinib affect VEGF-mediated cell proliferation, migration, invasion Via blocking VEGFR2\/RAF\/MEK\/ERK and PI3K\/AKT pathways in cholangiocarcinoma cell.","volume":"18","author":"Huang","year":"2018","journal-title":"BMC Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coph.2014.11.010","article-title":"Etiology of angiogenesis inhibition-related hypertension.","volume":"21","author":"Lankhorst","year":"2015","journal-title":"Curr Opin Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/cvr\/cvz022","article-title":"Vascular cardio-oncology: vascular endothelial growth factor inhibitors and hypertension.","volume":"115","author":"Versmissen","year":"2019","journal-title":"Cardiovasc Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00424-009-0763-y","article-title":"Endothelium-derived endothelin-1.","volume":"459","author":"Thorin","year":"2010","journal-title":"Pflugers Arch."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1152\/japplphysiol.00816.2019","article-title":"Endothelin-1-induced endothelial microvesicles impair endothelial cell function.","volume":"128","author":"Brewster","year":"2020","journal-title":"J Appl Physiol (1985)."},{"key":"B12","doi-asserted-by":"publisher","first-page":"I319","DOI":"10.1161\/circulationaha.105.001503","article-title":"Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway.","volume":"114","author":"Ramzy","year":"2006","journal-title":"Circulation."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.2174\/092986708786242831","article-title":"RhoA\/Rho-kinase as a therapeutic target in asthma.","volume":"15","author":"Kume","year":"2008","journal-title":"Curr Med Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/cvr\/cvx103","article-title":"Enhanced endothelin-1\/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial hypertrophy.","volume":"113","author":"Tsai","year":"2017","journal-title":"Cardiovasc Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1161\/hypertensionaha.119.14338","article-title":"Loss of Arhgef11 in the Dahl salt-sensitive rat protects against hypertension-induced renal injury.","volume":"75","author":"Johnson","year":"2020","journal-title":"Hypertension."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0132553","DOI":"10.1371\/journal.pone.0132553","article-title":"Allelic variants in arhgef11 Via the rho-rock pathway are linked to epithelial-mesenchymal transition and contributes to kidney injury in the DAHL salt-sensitive rat.","volume":"10","author":"Jia","year":"2015","journal-title":"PLoS One."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1097\/hjh.0000000000000326","article-title":"Rho kinase inhibition mitigates sunitinib-induced rise in arterial pressure and renal vascular resistance but not increased renal sodium reabsorption.","volume":"32","author":"Grisk","year":"2014","journal-title":"J Hypertens."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/jcm9051328","article-title":"Rock (RhoA\/Rho Kinase) in cardiovascular-renal pathophysiology: a review of new advancements.","volume":"9","author":"Seccia","year":"2020","journal-title":"J Clin Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/circresaha.108.188524","article-title":"Rock isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells.","volume":"104","author":"Wang","year":"2009","journal-title":"Circ Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.lfs.2016.01.008","article-title":"Endothelin-1\/endothelin a receptor axis activates RHOA Gtpase in epithelial ovarian cancer.","volume":"159","author":"Tocci","year":"2016","journal-title":"Life Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1161\/hypertensionaha.117.09925","article-title":"Three-month endothelial human endothelin-1 overexpression causes blood pressure elevation and vascular and kidney injury.","volume":"71","author":"Coelho","year":"2018","journal-title":"Hypertension."},{"key":"B22","doi-asserted-by":"publisher","first-page":"G63","DOI":"10.1152\/ajpgi.00370.2016","article-title":"Ca2+\/Calmodulin\/Mlck pathway initiates, and Rhoa\/Rock maintains, the internal anal sphincter smooth muscle tone.","volume":"312","author":"Rattan","year":"2017","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1023\/b:mcbi.0000021373.14288.00","article-title":"Myosin phosphatase: structure, regulation and function.","volume":"259","author":"Ito","year":"2004","journal-title":"Mol Cell Biochem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1152\/physrev.00023.2003","article-title":"Ca2+ sensitivity of smooth muscle and nonmuscle myosin Ii: modulated by G proteins, kinases, and myosin phosphatase.","volume":"83","author":"Somlyo","year":"2003","journal-title":"Physiol Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.jfma.2021.03.031","article-title":"Small chemical compounds Y16 and Rhosin can inhibit calcium sensitization pathway in vascular smooth muscle cells of spontaneously hypertensive rats.","volume":"120","author":"Chiu","year":"2021","journal-title":"J Formos Med Assoc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1200\/jco.20.01920","article-title":"Camrelizumab plus apatinib in patients with advanced cervical cancer (Clap): a multicenter, open-label, single-arm, phase Ii trial.","volume":"38","author":"Lan","year":"2020","journal-title":"J Clin Oncol."},{"key":"B27","first-page":"153","article-title":"Health behaviours among women diagnosed with breast tumours.","volume":"37","author":"Podkowa","year":"2014","journal-title":"Pol Merkur Lekarski."},{"key":"B28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jnutbio.2004.05.004","article-title":"Effects of intravenous betaine on methionine-loading-induced plasma homocysteine elevation in rats.","volume":"15","author":"Yagisawa","year":"2004","journal-title":"J Nutr Biochem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0210613","DOI":"10.1371\/journal.pone.0210613","article-title":"Recombinant human growth hormone (Rhgh) treatment of Mkn-45 xenograft mice improves nutrition status and strengthens immune function without promoting tumor growth.","volume":"14","author":"Wei","year":"2019","journal-title":"PLoS One."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1158\/1078-0432.Ccr-20-2571","article-title":"Camrelizumab in combination with apatinib in patients with advanced hepatocellular carcinoma (Rescue): a nonrandomized, open-label, phase Ii Trial.","volume":"27","author":"Xu","year":"2021","journal-title":"Clin Cancer Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1158\/2326-6066.Cir-17-0640","article-title":"Low-dose apatinib optimizes tumor microenvironment and potentiates antitumor effect of Pd-1\/Pd-L1 blockade in lung cancer.","volume":"7","author":"Zhao","year":"2019","journal-title":"Cancer Immunol Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00262-020-02576-x","article-title":"Anti-angiogenesis therapy overcomes the innate resistance to Pd-1\/Pd-L1 blockade in Vegfa-overexpressed mouse tumor models.","volume":"69","author":"Wang","year":"2020","journal-title":"Cancer Immunol Immunother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/aps.2018.16","article-title":"Combined treatment with apatinib and docetaxel in A549 xenograft mice and its cellular pharmacokinetic basis.","volume":"39","author":"Feng","year":"2018","journal-title":"Acta Pharmacol Sin."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1111\/cas.14168","article-title":"Apatinib induces 3-hydroxybutyric acid production in the liver of mice by peroxisome proliferator-activated receptor \u03b1 activation to aid its antitumor effect.","volume":"110","author":"Feng","year":"2019","journal-title":"Cancer Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"106858","DOI":"10.1016\/j.intimp.2020.106858","article-title":"Apatinib enhanced Anti-Pd-1 therapy for colon cancer in mice via promoting PD-l1 expression.","volume":"88","author":"Cai","year":"2020","journal-title":"Int Immunopharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/08820139.2021.1887887","article-title":"Inhibiting the rock pathway ameliorates acute lung injury in mice following myocardial ischemia\/reperfusion.","volume":"51","author":"Liu","year":"2021","journal-title":"Immunol Invest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cardiores.2003.12.004","article-title":"Inhibition of Rho-kinase protects the heart against ischemia\/reperfusion injury.","volume":"61","author":"Bao","year":"2004","journal-title":"Cardiovasc Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/tox.23135","article-title":"Rock inhibitor attenuates carbon blacks-induced pulmonary fibrosis in mice Via Rho\/Rock\/Nf-Kappa B pathway.","volume":"36","author":"Yan","year":"2021","journal-title":"Environ Toxicol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s10120-021-01159-8","article-title":"Apatinib induced ferroptosis by lipid peroxidation in gastric cancer.","volume":"24","author":"Zhao","year":"2021","journal-title":"Gastric Cancer."},{"key":"B40","doi-asserted-by":"publisher","first-page":"107929","DOI":"10.1016\/j.intimp.2021.107929","article-title":"Pd-1 inhibitor combined with apatinib modulate the tumor microenvironment and potentiate anti-tumor effect in mice bearing gastric cancer.","volume":"99","author":"Chen","year":"2021","journal-title":"Int Immunopharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.21037\/tcr-21-207","article-title":"Apatinib inhibits pancreatic cancer growth, migration and invasion through the Pi3k\/Akt and Erk1\/2\/Mapk pathways.","volume":"10","author":"Hu","year":"2021","journal-title":"Transl Cancer Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.bulcan.2019.03.012","article-title":"Her2-specific chimeric antigen receptor-engineered natural killer cells combined with apatinib for the treatment of gastric cancer.","volume":"106","author":"Wu","year":"2019","journal-title":"Bull Cancer."},{"key":"B43","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.neo.2016.07.002","article-title":"Inhibition of Rho-associated kinase 1\/2 attenuates tumor growth in murine gastric cancer.","volume":"18","author":"Hinsenkamp","year":"2016","journal-title":"Neoplasia."},{"key":"B44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.pharmthera.2012.12.003","article-title":"Role of Rho-kinase and its inhibitors in pulmonary hypertension.","volume":"137","author":"Duong-Quy","year":"2013","journal-title":"Pharmacol Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejphar.2018.03.014","article-title":"Diverse signalling of the platelet P2y(1) receptor leads to a dichotomy in platelet function.","volume":"827","author":"Amison","year":"2018","journal-title":"Eur J Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/jcp.28965","article-title":"Rki-1447 suppresses colorectal carcinoma cell growth Via disrupting cellular bioenergetics and mitochondrial dynamics.","volume":"235","author":"Li","year":"2020","journal-title":"J Cell Physiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.7150\/thno.54525","article-title":"Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension.","volume":"11","author":"Luo","year":"2021","journal-title":"Theranostics."},{"key":"B48","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/cvr\/cvy207","article-title":"Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice.","volume":"115","author":"Zhao","year":"2019","journal-title":"Cardiovasc Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/5587","article-title":"An essential part for rho-associated kinase in the transcellular invasion of tumor cells.","volume":"5","author":"Itoh","year":"1999","journal-title":"Nat Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/jhep.2001.22652","article-title":"Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632.","volume":"33","author":"Takamura","year":"2001","journal-title":"Hepatology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"7526","DOI":"10.3892\/mmr.2015.4404","article-title":"Rho-associated kinase inhibitor, Y-27632, inhibits the invasion and proliferation of T24 and 5367 bladder cancer cells.","volume":"12","author":"Jiang","year":"2015","journal-title":"Mol Med Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1053\/j.gastro.2014.03.052","article-title":"Loss of Smad4 alters Bmp signaling to promote colorectal cancer cell metastasis Via activation of rho and rock.","volume":"147","author":"Voorneveld","year":"2014","journal-title":"Gastroenterology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1016\/j.febslet.2006.06.056","article-title":"Involvement of Rho\/Rock signalling in small cell lung cancer migration through human brain microvascular endothelial cells.","volume":"580","author":"Li","year":"2006","journal-title":"FEBS Lett."},{"key":"B54","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1472-8206.2008.00658.x","article-title":"Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon Hypertensive rat artery smooth muscle.","volume":"23","author":"Freitas","year":"2009","journal-title":"Fundam Clin Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/hypertensionaha.112.199240","article-title":"Genetic variants in Arhgef11 are associated with kidney injury in the DAHL salt-sensitive rat.","volume":"60","author":"Williams","year":"2012","journal-title":"Hypertension."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1291\/hypres.31.1651","article-title":"Major haplotype block at the Rho-associated kinase 2 locus is associated with a lower risk of hypertension in a recessive manner: the hypgene study.","volume":"31","author":"Rankinen","year":"2008","journal-title":"Hypertens Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1161\/hypertensionaha.117.08856","article-title":"Recent advances in hypertension and cardiovascular toxicities with vascular endothelial growth factor inhibition.","volume":"70","author":"Touyz","year":"2017","journal-title":"Hypertension."},{"key":"B58","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/hypertensionaha.116.08565","article-title":"Salt sensitivity of angiogenesis inhibition-induced blood pressure rise: role of interstitial sodium accumulation?","volume":"69","author":"Lankhorst","year":"2017","journal-title":"Hypertension."},{"key":"B59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12576-015-0400-9","article-title":"The role of the Rhoa\/Rock pathway in gender-dependent differences in gastric smooth muscle contraction.","volume":"66","author":"Al-Shboul","year":"2016","journal-title":"J Physiol Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-030-35582-1_6","article-title":"Rho-rock signaling in normal physiology and as a key player in shaping the tumor microenvironment.","volume":"1223","author":"Porazinski","year":"2020","journal-title":"Adv Exp Med Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1042\/bst20180334","article-title":"Rho-rock signaling regulates tumor-microenvironment interactions.","volume":"47","author":"Johan","year":"2019","journal-title":"Biochem Soc Trans."},{"key":"B62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.biomaterials.2016.01.028","article-title":"Matrix rigidity differentially regulates invadopodia activity through rock1 and rock2.","volume":"84","author":"Jerrell","year":"2016","journal-title":"Biomaterials."},{"key":"B63","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev.physiol.68.040504.094707","article-title":"Signaling for contraction and relaxation in smooth muscle of the gut.","volume":"68","author":"Murthy","year":"2006","journal-title":"Annu Rev Physiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"39727","DOI":"10.1038\/srep39727","article-title":"The Rhoa\/Rock Pathway ameliorates adhesion and inflammatory infiltration induced by ages in glomerular endothelial cells.","volume":"7","author":"Rao","year":"2017","journal-title":"Sci Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.pharmthera.2018.09.001","article-title":"Druggable targets in the rho pathway and their promise for therapeutic control of blood pressure.","volume":"193","author":"Dee","year":"2019","journal-title":"Pharmacol Ther."},{"key":"B66","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1161\/hypertensionaha.109.149690","article-title":"Hypertension induced by the tyrosine kinase inhibitor sunitinib is associated with increased circulating endothelin-1 levels.","volume":"56","author":"Kappers","year":"2010","journal-title":"Hypertension."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1161\/hypertensionaha.114.04187","article-title":"Treatment of hypertension and renal injury induced by the angiogenesis inhibitor sunitinib: preclinical study.","volume":"64","author":"Lankhorst","year":"2014","journal-title":"Hypertension."},{"key":"B68","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/hypertensionaha.117.10490","article-title":"Vegfr (vascular endothelial growth factor receptor) inhibition induces cardiovascular damage Via redox-sensitive processes.","volume":"71","author":"Neves","year":"2018","journal-title":"Hypertension."},{"key":"B69","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/cvr\/cvz021","article-title":"Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury.","volume":"115","author":"Neves","year":"2019","journal-title":"Cardiovasc Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ejcts.2010.08.005","article-title":"Endothelial integrity of radial artery grafts harvested by minimally invasive surgery\u2013immunohistochemical studies of Cd31 and endothelial nitric oxide synthase expressions: a randomized controlled trial.","volume":"39","author":"Nowicki","year":"2011","journal-title":"Eur J Cardiothorac Surg."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.7150\/ijbs.7502","article-title":"The vascular endothelium and human diseases.","volume":"9","author":"Rajendran","year":"2013","journal-title":"Int J Biol Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s41401-020-00569-1","article-title":"The vascular endothelial growth factor trap aflibercept induces vascular dysfunction and hypertension via attenuation of Enos\/No signaling in mice.","volume":"42","author":"Dong","year":"2021","journal-title":"Acta Pharmacol Sin."},{"key":"B73","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1161\/01.Atv.0000191634.13057.15","article-title":"Circulating Cd31+\/Annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease.","volume":"26","author":"Werner","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ejvs.2003.12.023","article-title":"Immunocytochemical study on endothelial integrity of saphenous vein grafts harvested by minimally invasive surgery with the use of vascular mayo stripers. A randomized controlled trial.","volume":"27","author":"Nowicki","year":"2004","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B75","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mcna.2016.08.002","article-title":"The hypertensive myocardium: from microscopic lesions to clinical complications and outcomes.","volume":"101","author":"Moreno","year":"2017","journal-title":"Med Clin North Am."},{"key":"B76","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.acthis.2018.10.004","article-title":"Hypertension-induced changes in the rat myocardium during the development of cardiac hypertrophy \u2013 a comparison between the left and the right ventricle.","volume":"121","author":"Iliev","year":"2019","journal-title":"Acta Histochem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"H2598","DOI":"10.1152\/ajpheart.01393.2006","article-title":"Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.","volume":"292","author":"Hamid","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1152\/physiol.00033.2006","article-title":"Decompensation of cardiac hypertrophy: cellular mechanisms and novel Therapeutic Targets.","volume":"22","author":"Diwan","year":"2007","journal-title":"Physiology (Bethesda)."},{"key":"B79","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.atherosclerosis.2012.01.046","article-title":"Coptisine exert cardioprotective effect through anti-oxidative and inhibition of Rhoa\/Rho kinase pathway on isoproterenol-induced myocardial infarction in rats.","volume":"222","author":"Gong","year":"2012","journal-title":"Atherosclerosis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.atherosclerosis.2013.10.003","article-title":"Coptisine protects rat heart against myocardial ischemia\/reperfusion injury by suppressing myocardial apoptosis and inflammation.","volume":"231","author":"Guo","year":"2013","journal-title":"Atherosclerosis."}],"updated-by":[{"DOI":"10.3389\/fcvm.2022.1070597","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000}}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.873829\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T07:39:29Z","timestamp":1666856369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.873829\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":80,"alternative-id":["10.3389\/fcvm.2022.873829"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.873829","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"article-number":"873829"}}